Zolpidem Tartrate Tablet, Coated
Product Images NDC 0781-5317

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 0781-5317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem 01

FDA Label Image

Zolpidem 02

Zolpidem Tartrate Tablets, USP are a medication provided by Sandoz. Each tablet contains 5 mg of Zolpidem tartrate. The usual adult dosage is one or two tablets at bedtime as directed. The medication guide should be provided separately to each patient. The drug should be kept out of reach of children and stored in tight, light-resistant, and child-resistant containers. The finished drug product is manufactured by Lek Pharmaceuticals d.d. in Slovenia for Sandoz Inc. in New Jersey. The tablets contain an imprint, but the text does not provide information about the imprint.*

FDA Label Image

Zolpidem 03

This is a description of prescription medication, Zolpidem Tartrate Tablets USP, manufactured by Lek Pharmaceuticals d.d. in Slovenia and distributed by Sandoz Inc., based in Princeton, NJ. The tablet contains 10mg of zolpidem tartrate, and the recommended adult dosage is one tablet at bedtime. The medication guide should be given to each patient separately by the pharmacist. The drug should be stored in a container that is child-resistant and light-resistant at controlled room temperature. Pharmacy technicians should keep this and all drugs out of reach of children. There is an imprint area for tracking and identification purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.